Results
1
-
1
of
1
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
,
European Journal of Nuclear Medicine and Molecular Imaging
[DOI: 10.1007/s00259-010-1596-9]